Clinical Trial Update: Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the efficacy and safety of squalamine lactate eye drops in subjects with neovascular age-related macular degeneration; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Squalamine lactate eye drops (squalamine lactate)

Snippet

Sponsor: Ohr Pharmaceutical Inc. | Conditions: Neovascular Age Related Macular Degeneration | Phase 2 | Status: COMPLETED